Table of Content

1. Introduction



2. Research Methodology



3. Executive Summary



4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges


5. Genetic Testing Market



6. Market Share
6.1 By Type
6.2 By Product
6.3 By Technology
6.4 By Disease
6.5 By End User
6.6 By Countries


7. Type
7.1 Predictive Testing
7.2 Carrier Testing
7.3 Prenatal and Newborn Testing
7.4 Diagnostic Testing
7.5 Pharmacogenomic Testing
7.6 Nutrigenomic Testing
7.7 Others


8. Product
8.1 Consumables
8.2 Equipments
8.3 Software & Services


9. Technology
9.1 PCR
9.2 DNA Sequencing
9.3 Microarrays
9.4 Others


10. Disease
10.1 Cancer
10.2 Genetic Diseases
10.3 Cardiovascular Diseases
10.4 Rare Diseases
10.5 Infectious Diseases
10.6 Others


11. End User
11.1 Hospitals & Clinics
11.2 Diagnostic Laboratories
11.3 Others


12. Countries
12.1 North America

12.1.1 United States
12.1.2 Canada

12.2 Europe

12.2.1 France
12.2.2 Germany
12.2.3 Italy
12.2.4 Spain
12.2.5 United Kingdom
12.2.6 Belgium
12.2.7 Netherland
12.2.8 Turkey

12.3 Asia Pacific

12.3.1 China
12.3.2 Japan
12.3.3 India
12.3.4 South Korea
12.3.5 Thailand
12.3.6 Malaysia
12.3.7 Indonesia
12.3.8 Australia
12.3.9 New Zealand

12.4 Latin America

12.4.1 Brazil
12.4.2 Mexico
12.4.3 Argentina

12.5 Middle East & Africa

12.5.1 Saudi Arabia
12.5.2 UAE
12.5.3 South Africa


13. Porter’s Five Forces Analysis
13.1 Bargaining Power of Buyers
13.2 Bargaining Power of Suppliers
13.3 Degree of Rivalry
13.4 Threat of New Entrants
13.5 Threat of Substitutes


14. SWOT Analysis
14.1 Strength
14.2 Weakness
14.3 Opportunity
14.4 Threat


15. Key Players Analysis
15.1 Abbott Laboratories

15.1.1 Overview
15.1.2 Recent Development
15.1.3 Financial Insights

15.2 Danaher Corporation (Cepheid Inc.)

15.2.1 Overview
15.2.2 Recent Development
15.2.3 Financial Insights

15.3 Illumina Inc.

15.3.1 Overview
15.3.2 Recent Development
15.3.3 Financial Insights

15.4 BioRad Laboratories Inc.

15.4.1 Overview
15.4.2 Recent Development
15.4.3 Financial Insights

15.5 F Hoffmann-La Roche AG

15.5.1 Overview
15.5.2 Recent Development
15.5.3 Financial Insights

15.6 Diasorin

15.6.1 Overview
15.6.2 Recent Development
15.6.3 Financial Insights

15.7 Revvity Inc.

15.7.1 Overview
15.7.2 Recent Development
15.7.3 Financial Insights

15.8 Thermo Fisher Scientific Inc.

15.8.1 Overview
15.8.2 Recent Development
15.8.3 Financial Insights



List of Figures

0

List of Tables

0